New Biobanking LIMS Accelerator for Managing COVID-19 Testing

LabVantage Solutions, a provider of laboratory informatics solutions and services, developed a new purpose-built COVID-19 laboratory information management system (LIMS) solution. The solution enables laboratories to enter biospecimens into a biobank and rapidly begin COVID-19-related testing and research, the company reported in an April 28, 2020 press release.

The LabVantage COVID-19 Biobanking Accelerator is built on the company’s LIMS and biobanking platforms. The solution is delivered as a comprehensive software-as-a-service (SaaS) solution, requires no infrastructure investment, and is pre-configured, which means minimal implementation time is needed with a go-live start possible in less than four weeks, according to the company.

The accelerator includes full biobanking capabilities and COVID-19 extraction and testing workflows with related master data for rapid use. The company reports that the solution incorporates multiple protocols defined by the Centers for Disease Control and Prevention for COVID-19 testing and can easily accommodate additional standard and customized protocols for testing using a variety of approaches, such as reverse transcription polymerase chain reaction, isothermal nucleic acid amplification, and serology.

Source: LabVantage